Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-23-001563

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 14, 2023 60.04M sh
Current Liabilities Q2 2023 · Jun 30, 2023 $199.49K
Current Liabilities Q2 2023 · Dec 31, 2022 $201.12K
Current Assets Q2 2023 · Jun 30, 2023 $526.16K
Current Assets Q2 2023 · Dec 31, 2022 $657.54K
Total Assets Q2 2023 · Jun 30, 2023 $539.15K
Total Assets Q2 2023 · Dec 31, 2022 $687.49K
Gross Profit Q2 2023 · Jun 30, 2023 $0
Gross Profit Q2 2023 · Jun 30, 2023 $0
Gross Profit Q2 2023 · Jun 30, 2022 $0
Gross Profit Q2 2023 · Jun 30, 2022 $76.5K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $0
Cost Of Revenue Q2 2023 · Jun 30, 2023 $0
Cost Of Revenue Q2 2023 · Jun 30, 2022 $0
Cost Of Revenue Q2 2023 · Jun 30, 2022 $222K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$83.65K
Stockholders Equity Q2 2023 · Jun 30, 2022 $574.89K
Stockholders Equity Q2 2023 · Mar 31, 2022 $643.22K
Stockholders Equity Q2 2023 · Dec 31, 2021 $643.71K
Sga Expense Q2 2023 · Jun 30, 2022 $1.48M
Sga Expense Q2 2023 · Jun 30, 2022 $2.96M
Rd Expense Q2 2023 · Jun 30, 2022 $2.52M
Rd Expense Q2 2023 · Jun 30, 2022 $5.04M
Net Income Q2 2023 · Jun 30, 2022 −$4M
Net Income Q2 2023 · Jun 30, 2022 −$7.93M
Net Income Q2 2023 · Mar 31, 2022 −$3.93M
Operating Income Q2 2023 · Jun 30, 2022 −$4M
Operating Income Q2 2023 · Jun 30, 2022 −$7.93M
Revenue Q2 2023 · Jun 30, 2022 $0
Revenue Q2 2023 · Jun 30, 2022 $298.5K